Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04893551 |
| Title | A Study of Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Participants |
| Recruitment | Terminated |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | BerGenBio ASA |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | NOR | GBR |